Literature DB >> 22398747

A critical role for the inducible proteasomal subunits LMP7 and MECL1 in cytokine production by activated murine splenocytes.

Cheryl E Rockwell1, John J Monaco, Nilofer Qureshi.   

Abstract

BACKGROUND AND
PURPOSE: The proteasome is a multi-subunit complex that proteolytically cleaves proteins. The replacement of the constitutive proteasome subunits β1, β2, and/or β5 with the IFNγ-inducible subunits LMP2, MECL1, and/or LMP7 results in the 'immunoproteasome'. The inducible subunits change the cleavage specificities of the proteasome, but it is unclear whether they have functions in addition to this. The purpose of the present study was to determine the role of the proteasome in general, as well as LMP7 and MECL1 specifically, with regard to cytokine production by activated primary splenocytes.
METHODS: A LMP7/MECL1-null mouse was engineered to determine the roles of these subunits in cytokine production. Isolated splenocytes from wild-type and LMP7/MECL1-/- mice were treated with lactacystin and activated with PMA and ionomycin and subsequently cytokine mRNA levels were quantified.
RESULTS: The present study demonstrates that LMP7/MECL1 regulates the expression of IFNγ, IL4, IL10, IL2Rβ, GATA3, and t-bet. In contrast, the regulation of IL2, IL13, TNFα, and IL2Rα by the proteasome appears to occur independently of LMP7/MECL1.
CONCLUSIONS: Collectively, the present study demonstrates that LMP7 and MECL1 regulate cytokine expression, suggesting this system represents a novel mechanism for the regulation of cytokines and cytokine signaling.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22398747      PMCID: PMC3702019          DOI: 10.1159/000336335

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  31 in total

1.  Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress.

Authors:  Ulrike Seifert; Lukasz P Bialy; Frédéric Ebstein; Dawadschargal Bech-Otschir; Antje Voigt; Friederike Schröter; Timour Prozorovski; Nicole Lange; Janos Steffen; Melanie Rieger; Ulrike Kuckelkorn; Orhan Aktas; Peter-M Kloetzel; Elke Krüger
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

2.  Differential effects of lactacystin on cytokine production in activated Jurkat cells and murine splenocytes.

Authors:  Cheryl E Rockwell; Nilofer Qureshi
Journal:  Cytokine       Date:  2010-04-27       Impact factor: 3.861

3.  Immunoproteasome subunit deficiencies impact differentially on two immunodominant influenza virus-specific CD8+ T cell responses.

Authors:  Ken C Pang; Megan T Sanders; John J Monaco; Peter C Doherty; Stephen J Turner; Weisan Chen
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 4.  Catalytic mechanism and assembly of the proteasome.

Authors:  António J Marques; R Palanimurugan; Ana C Matias; Paula C Ramos; R Jürgen Dohmen
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

5.  A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model.

Authors:  Julia Reis; Xiaoyu Tan; Rongjie Yang; Cheryl E Rockwell; Christopher J Papasian; Stefanie N Vogel; David C Morrison; Asaf A Qureshi; Nilofer Qureshi
Journal:  Innate Immun       Date:  2008-10       Impact factor: 2.680

6.  Critical role for the immunoproteasome subunit LMP7 in the resistance of mice to Toxoplasma gondii infection.

Authors:  Liping Tu; Chikako Moriya; Takashi Imai; Hidekazu Ishida; Kohhei Tetsutani; Xuefeng Duan; Shigeo Murata; Keiji Tanaka; Chikako Shimokawa; Hajime Hisaeda; Kunisuke Himeno
Journal:  Eur J Immunol       Date:  2009-12       Impact factor: 5.532

7.  Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes.

Authors:  Dmitriy Lukashev; Boris Klebanov; Hidefumi Kojima; Alex Grinberg; Akiko Ohta; Ludmilla Berenfeld; Roland H Wenger; Akio Ohta; Michail Sitkovsky
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

8.  Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses.

Authors:  Scott E Hensley; Damien Zanker; Brian P Dolan; Alexandre David; Heather D Hickman; Alan C Embry; Cara N Skon; Kristie M Grebe; Thomas A Griffin; Weisan Chen; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2010-03-12       Impact factor: 5.422

9.  Proteasome inhibition suppresses essential immune functions of human CD4+ T cells.

Authors:  Carsten Berges; Heinrich Haberstock; Dominik Fuchs; Marion Miltz; Mahmoud Sadeghi; Gerhard Opelz; Volker Daniel; Cord Naujokat
Journal:  Immunology       Date:  2008-01-23       Impact factor: 7.397

10.  A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis.

Authors:  Tony Muchamuel; Michael Basler; Monette A Aujay; Erika Suzuki; Khalid W Kalim; Christoph Lauer; Catherine Sylvain; Eileen R Ring; Jamie Shields; Jing Jiang; Peter Shwonek; Francesco Parlati; Susan D Demo; Mark K Bennett; Christopher J Kirk; Marcus Groettrup
Journal:  Nat Med       Date:  2009-06-14       Impact factor: 53.440

View more
  8 in total

Review 1.  Proteasome protease mediated regulation of cytokine induction and inflammation.

Authors:  Nilofer Qureshi; David C Morrison; Julia Reis
Journal:  Biochim Biophys Acta       Date:  2012-06-19

2.  Activity-based near-infrared fluorescent probe for LMP7: a chemical proteomics tool for the immunoproteasome in living cells.

Authors:  Lalit Kumar Sharma; Na-Ra Lee; Eun Ryoung Jang; Beilei Lei; Chang-Guo Zhan; Wooin Lee; Kyung-Bo Kim
Journal:  Chembiochem       Date:  2012-07-17       Impact factor: 3.164

Review 3.  Activity-based imaging probes of the proteasome.

Authors:  Kimberly Cornish Carmony; Kyung Bo Kim
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

Review 4.  The Immunoproteasome in oxidative stress, aging, and disease.

Authors:  Helen K Johnston-Carey; Laura C D Pomatto; Kelvin J A Davies
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-04-20       Impact factor: 8.250

5.  Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.

Authors:  Michael Basler; Sarah Mundt; Tony Muchamuel; Carlo Moll; Jing Jiang; Marcus Groettrup; Christopher J Kirk
Journal:  EMBO Mol Med       Date:  2014-01-16       Impact factor: 12.137

6.  Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNΓ.

Authors:  Khetam Ghannam; Lorena Martinez-Gamboa; Lydia Spengler; Sabine Krause; Biljana Smiljanovic; Marc Bonin; Salyan Bhattarai; Andreas Grützkau; Gerd-R Burmester; Thomas Häupl; Eugen Feist
Journal:  PLoS One       Date:  2014-08-06       Impact factor: 3.240

Review 7.  The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer.

Authors:  Satyendra Chandra Tripathi; Disha Vedpathak; Edwin Justin Ostrin
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600

8.  Blood Immunoproteasome Activity Is Regulated by Sex, Age and in Chronic Inflammatory Diseases: A First Population-Based Study.

Authors:  Ilona Elisabeth Kammerl; Claudia Flexeder; Stefan Karrasch; Barbara Thorand; Margit Heier; Annette Peters; Holger Schulz; Silke Meiners
Journal:  Cells       Date:  2021-11-28       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.